CVS Health
CVS
1,834 hedge funds and large institutions have $82.5B invested in CVS Health in 2025 Q3 according to their latest regulatory filings, with 212 funds opening new positions, 668 increasing their positions, 724 reducing their positions, and 109 closing their positions.
94% more first-time investments, than exits
New positions opened: 212 | Existing positions closed: 109
21% more call options, than puts
Call options by funds: $2.26B | Put options by funds: $1.88B
8% more capital invested
Capital invested by funds: $76.4B → $82.5B (+$6.1B)
4% more funds holding
Funds holding: 1,757 → 1,834 (+77)
0.49% less ownership
Funds ownership: 86.73% → 86.23% (-0.49%)
8% less repeat investments, than reductions
Existing positions increased: 668 | Existing positions reduced: 724
3% less funds holding in top 10
Funds holding in top 10: 33 → 32 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$576M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$346M |
| 3 |
Amundi
Paris,
France
|
+$249M |
| 4 |
Capital Research Global Investors
Los Angeles,
California
|
+$154M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$150M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$340M |
| 2 |
Jennison Associates
New York
|
-$207M |
| 3 |
BlackRock
New York
|
-$195M |
| 4 |
Hotchkis & Wiley Capital Management
Los Angeles,
California
|
-$183M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$156M |
CVS Hedge Fund Activity: Q3 2025 in Review
1,834 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in CVS Health (CVS) for Q3 2025, worth a combined $82.5B — up 8% from $76.4B a quarter earlier.
Buyers outnumbered sellers: 212 funds opened new CVS positions and 109 closed out — a net gain of 103 holders — while 668 added to existing stakes and 724 trimmed.
The largest buyer was JP Morgan Chase, adding an estimated $576M. The largest seller was Citadel Advisors, cutting an estimated $340M.
- 1,834 institutional investors held CVS Health (CVS) as of Q3 2025, up from 1,757 in Q2 2025.
- Funds reported $82.5B of CVS Health stock for Q3 2025, up 8% quarter-over-quarter.
- 212 funds opened new CVS Health positions in Q3 2025 and 109 closed out, a net change of +103 holders.
- The largest CVS Health buyer in Q3 2025 was JP Morgan Chase, an estimated $576M added.
- The largest CVS Health seller in Q3 2025 was Citadel Advisors, an estimated $340M sold.
Based on aggregated 13F filings for Q3 2025.